Availability of advanced immunofluorescent assays kits and reagents, growing healthcare burden of chronic diseases, and increasing investments in healthcare sector are key factors driving market growth The global immunofluorescent assay (IFA) market size is expected to reach USD 4.01 billion by 2028 at a CAGR of 6.3%, according to the latest report by Reports and Data....